13 July 2020

Oncode Quarterly Magazine - July

Vesna de Jong

In the past quarter we said goodbye to one of the driving forces behind the idea of Oncode: Angus Livingstone. Upon his well-deserved retirement, his position as Valorization Director was taken over by Chris De Jonghe. In this magazine, Angus and Chris reflect on and look ahead to what Oncode has to offer.

In months where digital is the new standard, we took a deep-dive into one of our labs where the work on outsmarting cancer is mostly through digital research. How can computational biology further cancer research? Lodewyk Wessels and his team give you a sneak peek into building the ultimate computational model to understand drug responses in cancer treatment. In a more personal interview, we get to know Oncode Investigator Puck Knipscheer. With agricultural roots and a passion for biology, physics and chemistry, her academic career took her from Wageningen, to Boston and back to Utrecht.

Click here to open the magazine

Other News

Kops website
New biosensor measures activity of control enzyme MPS1
Researchers from the group of Oncode Investigator Geert Kops (Hubrecht Institute) have developed a biosensor that can precisely depict the activity of the MPS1 enzyme in living cells. MPS1 is responsible for accurate distribution of DNA during cell division; errors in this process can lead to cancer. Using the new biosensor, the researchers discovered that the MPS1 enzyme is significantly less active in colorectal cancer cells. The results were published in the scientific journal Current Biology on the 3rd of September.
Bianca-OliviaNita
Compounds
Pre-existing immune-resistant cancer cells identified in melanoma
Researchers at the Netherlands Cancer Institute, led by Oncode Investigator Daniel Peeper with Julia Boshuizen as first author, have discovered a cluster of tumor cells that are refractory to immunotherapy and that exists even prior to treatment. This finding, which was published in the scientific journal Nature Communications, may lead to new therapies that eliminate cancer more effectively.
ElizeBrolsma

<span>Elize</span><span>Brolsma</span>

Elize is part of Oncode’s communication team. She has over 10 years of experience in the com-munication industry, both for commercial and non-profit organisations. After obtaining her bache-lor and master degree in communication at Utrecht University, Elize worked as a communication professional at a research institute, PR agency, law firm and internet company. She has a strong focus on external communications and Public Relations. At Oncode - together with her colleagues - Elize produces the monthly newsletters for Oncode Investigators & Researchers and the Oncode digital magazine. She publishes content for the Oncode website and is responsible for all social media channels. She enjoys discussing science with researchers and support them in their outreach.
11 impact value 1
Convey impact, get funding
In order to give our community hands-on advice on how to improve their grant writing, we hosted a 90- minute interactive webinar: Get Funding: Convey the impact of your science.
AmberLiu